- By Jackie Connor
- Posted February 6, 2017
Genetic Testing Accuracy Explained During the AmbrySpeaks-Los Angeles Event
In the first of seven dinner series events, on Tuesday, January 31st, Ambry Genetics presented to more than 45 attendees at Spago in Beverly Hills, California. The “AmbrySpeaks Tour—Accuracy and Innovation in the Era of Collaborative Genetics” challenges the common misconception that Next-generation sequencing (NGS) is 100 percent accurate,…
- By Deepti Babu, MS, CGC
- Posted February 2, 2017
Exome Sequencing Provides More Coverage Than You Think
Advances in molecular diagnostics offer clinicians more choices than ever when it comes to disease-targeted genetic testing for their patients.1 However, the amount of options can complicate deciding which test is best for each patient. Next generation sequencing (NGS)-based clinical genetic tests, such as multi-gene panel testing (MGPT), offer…
- By Jackie Connor
- Posted January 18, 2017
'AmbrySpeaks' Tour kicks off in Los Angeles
Ever since our initial publication of Sanger sequencing confirmation was featured in The Journal of Molecular Diagnostics, in addition to our accompanying presentation at the National Society of Genetic Counselors conference last fall, Ambry has been touting our superior scientifically-proven genetic testing. Now we are bringing the message that…
- By Deepti Babu, MS, CGC
- Posted December 23, 2016
New Research on Male Breast Cancer: Unexpected Results and Insights
Breast cancer in men may be rare in the average population, but is far more common in people with an underlying genetic predisposition. Finding a cancer gene mutation in a man with breast cancer can drastically impact medical management for him and his family members (who may otherwise not be screened for the disease). Current guidelines recommend…
- By Jackie Connor
- Posted December 18, 2016
Congratulations to the 2016 Battle for the Breasts Winners!
The Mauli Ola Foundation has announced the winning team of their 3rd annual Battle for the Breasts (B4TB) online surf contest, as of the end of October, which was also Breast Cancer Awareness month. As a proud sponsor of the competition, Ambry would like to congratulate the winning team of professional surfer, Dimity Stoyle of Maroochydore, Queensland,…
- By Jackie Connor
- Posted December 14, 2016
Dr. Fergus Couch Talks with Ambry about Recent Study Findings
At Ambry we had the exciting opportunity to talk with Dr. Fergus Couch, Mayo Clinic Researcher, about his involvement with our Mayo Clinic research collaboration. “Breast cancer risks associated with mutations in cancer predisposition genes identified by clinical genetic testing of 60,000 breast cancer patients,” which was the largest hereditary…
- By Jackie Connor
- Posted November 23, 2016
'The Color Violet' Documentary to Premiere at American Epilepsy Society's Annual Meeting
Ambry is proud to introduce “The Color Violet,” a documentary created in collaboration with the PCDH19 Alliance and UCSF Benioff Children’s Hospital. The film explores the life of a 9-year-old girl, Violet McManus, and her family’s collective journey with PCDH19-related epilepsy. The film also explores the latest available treatments…
- By Jackie Connor
- Posted November 16, 2016
Quality Genetic Testing and Why it Matters on Lifetime's 'Access Health' Television
Genetic testing has become an impactful method for clinicians to help their patients confirm their chances of inheriting a genetic disease. Testing quality is an imperative element in determining a patient’s next steps and whether their family members should also be tested. On November 16th, Ambry CEO Aaron Elliott, PhD and Robina Smith, MD,…
- By Jackie Connor
- Posted November 7, 2016
Ambry Execs Discuss the Importance of Genetic Testing on Lifetime's "Access Health" Program
Genetic testing has helped research for breast cancer progress immeasurably, and thanks to some high profile cases, more women are opting for genetic testing when they go in for mammograms and other checkups. As a result, more companies are offering a variety of genetic tests geared towards detecting mutations in the BRCA1 and BRCA2…
- By Jackie Connor
- Posted November 3, 2016
Ambry Supports 'Movember' with Clinical Research, Testing Menu Updates and...Mustaches
The many male faces at Ambry are becoming a little scruffier in support of ‘Movember,’ an initiative dedicated to raising awareness about men’s health. While our guys forgo the barber and/or a daily shave, at Ambry, the meaning behind ‘Movember’ goes deeper than the mustachioed men on campus. Ambry’s constant push for more clinical…